Corporate
News

LR Health & Beauty SE continues growth trajectory in the 2024 financial year

• Sales increased to EUR 289.2 million
• EBITDA reported at EUR 27.3 million, burdened by one-off extraordinary effects
• Career plan realignment leads to significant boost in new sales careers
• Successful launch of new LR Aloe Via Magic Power Duo skincare range contributes to positive business outlook in 2025
• 2025 forecast: significant increase in EBITDA with stable to moderate sales growth

Ahlen, 25 April 2025 – LR Health & Beauty SE, Europe’s leading digital social commerce company for high-quality nutritional supplements and beauty products, today published its final audited financial results for 2024. With this, the Group confirms the preliminary figures for the 2024 financial year announced on 28 February 2025, according to which LR Health & Beauty SE achieved sales (revenue from goods sold) of EUR 289.2 million (2023: EUR 276.5 million), representing a year-on-year increase in sales of 4.6%. This increase was significantly driven by the realignment of the career plan, on the one hand, and the successful launches of the colour cosmetics line LR ZEITGARD Signature, and the intestinal metabolism treatment LR HEALTH MISSION, on the other. The LR Group therefore achieved its sales forecast for 2024, which it had raised in November to a range of EUR 288 to 292 million.

Furthermore, LR Health & Beauty SE achieved an EBITDA reported of EUR 27.3 million in the 2024 financial year, compared to EUR 31.4 million in the previous year. This was in line with the forecast for EBITDA reported, which had been adjusted in November to a range of EUR 26 to 29 million. In the reporting period, earnings development was particularly impacted by one-off, extraordinary effects related to the realignment of the career plan in the fourth quarter and the early refinancing of the bond in spring 2024. Normalized EBITDA amounted to EUR 32.6 million in 2024 (2023: EUR 35.4 million).

Dr Andreas Laabs, Chief Executive Officer (CEO) of LR Health & Beauty SE, elaborates on the Group’s strategic initiatives: “In 2024, we consistently executed our strategy and took a major step toward long-term corporate success with the realignment of our career plan. This year, we are again seeing a strong increase in the number of new distributors who are using our onboarding programmes to launch their careers. By continuing to digitalise our business processes, we are empowering our partner community to grow their careers successfully. At the same time, we are expanding our digital offering – whether through training, information, or sales initiatives.” 

Innovative product launches drive new growth opportunities

In 2025, the LR Group will continue to focus on expanding and optimising its product portfolio. The new LR Aloe Via Magic Power Duo skincare range was successfully launched in April. This innovative skincare range features an even more powerful fermented aloe vera extract.

Valdemaras Gordinskis, the LR Group’s Vice President Global Controlling and Investor Relations, comments: “Processing aloe vera has always been one of LR’s core competencies. Now, with the unique combination of pure aloe vera leaf gel and fermented aloe vera, we have taken skincare a step further. With the patented Aloe Via Magic Power Duo product solution, we are setting new standards in skincare and expanding our range of health and beauty products. For LR, product innovation is an important pillar on the path to sustained profitable growth.”

Positive outlook for 2025

LR Health & Beauty SE is well positioned to take advantage of the attractive growth opportunities in the health & beauty sectors. Against a backdrop of high uncertainty in the market environment and continued consumer reticence, LR expects stable to moderately rising sales (revenue from goods sold) in the 2025 financial year, based on conservative assumptions. Furthermore, given the expected sales development, operational improvements and the absence of extraordinary effects compared to the previous year, the Group is expected to achieve a significant year-on-year increase in EBITDA. 

The full 2024 Annual Report is available from today on the company website at https://ir.lrworld.com/. At the end of May 2025, LR will also publish the 2024 Sustainability Report and make it available for download here.

LR Group
Following the motto "More quality for your life" the LR Group with headquarters in Ahlen/Westphalia successfully produces and markets various high-quality nutritional supplements and cosmetic products in 32 countries. As an attractive social commerce company, LR supports the personal exchange in its community with efficient, digital solutions. The holistic tool "LR neo" offers the international partnership all business-relevant key figures and information for their LR business in one dashboard. 

LR has been firmly established on the market since 1985 as a "people business" company that focuses on people and personal advice. In times of changing working environments, the business model particularly appeals to those who are looking for more flexibility, a better work-life balance and greater financial independence.  

The processing of Aloe Vera has been one of the core competencies of LR for more than 20 years. Only the valuable inside of the leaf is used for the products. In Ahlen, the company has established one of the most modern Aloe Vera production sites for Aloe Vera Drinking Gels in Europe. 

In autumn 2009, LR founded the LR Global Kids Fund e.V., which supports deprived children and their families in many countries around the world efficiently and unbureaucratically in cooperation with local institutions. For further information on our commitment to sustainability, please read our sustainability report. 

LR currently has around 1,200 employees and hundreds of thousands of registered community members.

Your Contacts:

PR Contact:
LR Health & Beauty SE  
Almut Kellermeyer   
Head of Corporate Communication
Kruppstraße 55  
59227 Ahlen  
Phone: +49(0)2382 7813-106 
E-Mail: a.kellermeyer@LRworld.com  
https://ir.lrworld.com/ 

IR Contact: 
cometis AG 
Thorben Burbach 
Unter den Eichen 7 | Gebäude D 
65195 Wiesbaden 
Phone: +49(0)611 - 205855-23 
Fax: +49(0)611 - 205855-66 
E-Mail: burbach@cometis.de 

LR Health & Beauty SE achieves significant sales growth in the final quarter of 2024 and meets the sales and earnings forecast for the full year 2024
8.0% increase in sales in Q4 2024 to EUR 76.5 million, confirming growth trend 
Full-year sales at EUR 289.2 million, up 4.6% y-o-y
EBITDA reported of EUR 8.3 million in Q4 2024 and EUR 27.3 million in FY 2024 due to one-off charges 
Realignment of career plan and successful product launches such as LR ZEITGARD Signature provide positive momentum in 2024 and beyond

Ahlen, 28 February 2025 - LR Health & Beauty SE, Europe’s leading digital social commerce company in the area of high-quality nutritional supplements and cosmetic products, today publishes its figures for the fourth quarter of 2024 as well as preliminary sales and earnings figures for the full year 2024.

LR Health & Beauty SE closed the 2024 financial year with significant sales growth in the fourth quarter, confirming the growth trend of the third quarter. In the fourth quarter of 2024, LR achieved sales (revenue from goods sold) of EUR 76.5 million (Q4 2023: EUR 70.9 million), representing growth of 8.0%. For the full year 2024, LR Health & Beauty SE reports sales of EUR 289.2 million, compared to EUR 276.5 million in the previous year. This corresponds to an increase of 4.6% and is in line with the LR Group’s 2024 sales forecast of EUR 288 to 292 million, which had been raised in November.

“LR Group’s strong growth is confirmation that we are on the right track with our strategy. The positive performance in the final quarter of 2024 is primarily the result of the realignment of the career plan and the successful market launch of further product innovations. We’re constantly working to create the best possible conditions for the business success of our partners, who participated with great enthusiasm in a wide range of kick-off events at the beginning of the year. With LR ZEITGARD Signature, we have perfectly complemented our portfolio in the area of colour cosmetics. We are confident that this solid foundation will enable us to continue our growth trajectory in the year of LR’s 40th anniversary,” says Dr. Andreas Laabs, CEO of LR Health & Beauty SE.

In the fourth quarter of 2024, LR Health & Beauty SE generated EBITDA reported of EUR 8.3 million (Q4 2023: EUR 9.0 million). On a preliminary basis, EBITDA reported for the full year 2024 reached EUR 27.3 million, compared to EUR 31.4 million in 2023 and was therefore in line with the forecast for EBITDA reported adjusted in November to EUR 26 to 29 million. In particular, one-off extraordinary effects related to the realignment of the career plan in the fourth quarter and the early refinancing of the bond in spring 2024 had a negative impact on the earnings development in the financial year. Normalized EBITDA decreased to EUR 9.5 million in the fourth quarter of 2024, compared to EUR 10.2 million in the fourth quarter of the previous year. In the full year 2024, normalized EBITDA reached EUR 32.6 million on a preliminary basis (2023: EUR 35.4 million).

Valdemaras Gordinskis, Vice President Global Controlling and Investor Relations at LR Health & Beauty SE, comments: “In 2025, we will continue to focus on implementing further strategic measures. For example, we are stepping up the development of new product innovations in order to expand our range of high-quality nutritional supplements and cosmetic products. We will also focus on increasing the efficiency and profitability of the LR Group through operational improvements in production and logistics as well as the further digitalization of our sales activities.”

The report for the fourth quarter of 2024 is available online from today on the company website at https://ir.lrworld.com/. The final, audited figures for the 2024 financial year will be published on the company website at the end of April 2025, together with the annual report. 

* As issuer of the New Bond 2024/2028, LR Health & Beauty SE publishes the figures for the fourth quarter and the full year 2024 and for the relevant periods in the previous year. The previous year’s figures for 2023 may differ from the figures for 2023 published previously by LR Global Holding GmbH.
 

LR Group

Following the motto "More quality for your life" the LR Group with headquarters in Ahlen/Westphalia successfully produces and markets various high-quality nutritional supplements and cosmetic products in 32 countries. As an attractive social commerce company, LR supports the personal exchange in its community with efficient, digital solutions. The holistic tool "LR neo" offers the international partnership all business-relevant key figures and information for their LR business in one dashboard. 
 
LR has been firmly established on the market since 1985 as a "people business" company that focuses on people and personal advice. In times of changing working environments, the business model particularly appeals to those who are looking for more flexibility, a better work-life balance and greater financial independence.  
 
The processing of Aloe Vera has been one of the core competencies of LR for more than 20 years. Only the valuable inside of the leaf is used for the products. In Ahlen, the company has established one of the most modern Aloe Vera production sites for Aloe Vera Drinking Gels in Europe. 
 
In autumn 2009, LR founded the LR Global Kids Fund e.V., which supports deprived children and their families in many countries around the world efficiently and unbureaucratically in cooperation with local institutions. For further information on our commitment to sustainability, please read our sustainability report. 
 
LR currently has around 1,200 employees and hundreds of thousands of registered community members. 

Your Contacts: 
 
PR Contact:  
LR Health & Beauty SE  
Almut Kellermeyer   
Head of Corporate Communication  
Kruppstraße 55  
59227 Ahlen  
Phone: +49(0)2382 7813-106 
E-Mail: a.kellermeyer@LRworld.com 
https://ir.lrworld.com/ 
 
 
IR Contact: 
cometis AG 
Thorben Burbach 
Unter den Eichen 7 | Gebäude D 
65195 Wiesbaden 
Phone: +49(0)611 - 205855-23 
Fax: +49(0)611 - 205855-66 
E-Mail: burbach@cometis.de 

LR Health & Beauty SE publishes bond prospectus and applies for admission to trading of bonds on the corporate bond list of Nasdaq Stockholm

Ahlen, 26 February 2025 – On 4 March 2024, LR Health & Beauty SE (“LR SE”) issued senior secured floating rate bonds (2024/2028) in an amount of EUR 130,000,000 (the “Bonds”). Under the terms and conditions for the Bonds, LR SE has undertaken to apply for admission to trading of the Bonds on the corporate bond list of Nasdaq Stockholm. For the purpose of the admission to trading, LR SE has prepared a listing prospectus which has been approved by the Swedish Financial Supervisory Authority today. LR SE will submit an application for admission to trading of the Bonds and the first trading day on Nasdaq Stockholm is expected to be on or about 28 February 2025. 

The prospectus will be available at LR Group’s website, ir.lrworld.com/en/bond/ and the Swedish Financial Supervisory Authority’s website www.fi.se. 

LR Group

Following the motto "More quality for your life" the LR Group with headquarters in Ahlen/Westphalia successfully produces and markets various high-quality nutritional supplements and cosmetic products in 32 countries. As an attractive social commerce company, LR supports the personal exchange in its community with efficient, digital solutions. The holistic tool "LR neo" offers the international partnership all business-relevant key figures and information for their LR business in one dashboard. 
 
LR has been firmly established on the market since 1985 as a "people business" company that focuses on people and personal advice. In times of changing working environments, the business model particularly appeals to those who are looking for more flexibility, a better work-life balance and greater financial independence.  
 
The processing of Aloe Vera has been one of the core competencies of LR for more than 20 years. Only the valuable inside of the leaf is used for the products. In Ahlen, the company has established one of the most modern Aloe Vera production sites for Aloe Vera Drinking Gels in Europe. 
 
In autumn 2009, LR founded the LR Global Kids Fund e.V., which supports deprived children and their families in many countries around the world efficiently and unbureaucratically in cooperation with local institutions. For further information on our commitment to sustainability, please read our sustainability report. 
 
LR currently has around 1,200 employees and hundreds of thousands of registered community members. 

Your Contacts:

PR Contact:  
LR Health & Beauty SE  
Almut Kellermeyer   
Head of Corporate Communication  
Kruppstraße 55  
59227 Ahlen  
Phone: +49(0)2382 7813-106 
E-Mail: a.kellermeyer@LRworld.com 
https://ir.lrworld.com/ 

IR Contact: 
cometis AG 
Thorben Burbach 
Unter den Eichen 7 | Gebäude D 
65195 Wiesbaden 
Phone: +49(0)611 - 205855-23 
Fax: +49(0)611 - 205855-66 
E-Mail: burbach@cometis.de 

LR Health & Beauty SE further increases growth trend in the third quarter 

• Sales significantly increased by 7.2% to EUR 69.4 million in the third quarter of 2024
• In Q3 2024 EBITDA reported rose to EUR 7.3 million and normalized EBITDA increased to EUR 8.7 million
• Successful market launch of LR ZEITGARD Signature and realignment of the career plan increased the number of new distributors and led to higher sales
• Adjusted guidance for 2024: Sales range of EUR 288 million to EUR 292 million, EBITDA reported in the corridor of EUR 26 million to EUR 29 million

Ahlen, 26 November 2024 – LR Health & Beauty SE, Europe’s leading digital social commerce company in the area of high-quality nutritional supplements and cosmetic products, today published its figures for the third quarter of 2024 and the first nine months of 2024. Despite the challenging market environment, LR Health & Beauty SE increased sales (revenue from goods sold) by 7.2% to EUR 69.4 million in the third quarter of 2024 (Q3 2023: EUR 64.7 million). This resulted in sales for the first nine months of 2024 of EUR 212.7 million compared to EUR 205.6 million in the previous year, an increase of 3.4%. The recent market launch of the cosmetic product range LR ZEITGARD Signature and the realignment of the career plan for distributors made a major contribution to sales growth. 

On top of that, EBITDA reported increased in the third quarter of 2024 to EUR 7.3 million compared to EUR 7.1 million in the third quarter of the previous year. As a result, EBITDA reported in the first nine months of 2024 totaled EUR 19.0 million compared to EUR 22.4 million in the prior year period. Normalized EBITDA increased sharply from EUR 7.7 million in the third quarter of the previous year to EUR 8.7 million in the third quarter of 2024, resulting in a figure for the first nine months of EUR 23.1 million (9M 2023: EUR 25.2 million).  

Dr. Andreas Laabs, CEO of LR Health & Beauty SE, comments: "With the introduction of the new LR ZEITGARD Signature product category, we have achieved one of the most successful product launches in LR's history and seamlessly continued our journey of successful market launches of the recent past. In addition, we have further improved the attractiveness of our business model for distributors by realigning our career plan. We are currently experiencing a decent influx of new distributors and a significant increase in the number of successful careers. Accordingly, we are looking forward to continuing to grow significantly in 2024 and believe we are ideally positioned for an even more successful 2025.“

Based on the business results for the first nine months of 2024 and the realignment of the career plan for distributors in the third quarter of 2024, LR Health & Beauty SE is adjusting its forecast for sales and EBITDA reported for the full year 2024. LR Health & Beauty SE is increasing the sales guidance for the 2024 financial year and now expects a sales corridor of EUR 288 million to EUR 292 million. Management originally assumed that sales (revenue from goods sold) would be at the previous year's level (2023: EUR 276.5 million). The company is also adjusting its earnings expectations for 2024 and revising its forecast for EBITDA reported to be in the range of EUR 26 million to EUR 29 million. Originally, management expected a slightly lower to stable EBITDA figure year-on-year (2023: EUR 31.4 million). The underlying reason is that the realignment of the career plan for distributors in the third and fourth quarters of 2024 will lead to a significant increase in distributors, which will have a positive impact on sales development. At the same time, the result is burdened by refinancing costs incurred and, above all, by one-off, extraordinary effects in the low single-digit million euro range due to changes to the distributors' career plan.   

Valdemaras Gordinskis, Vice President Global Controlling and Investor Relations of LR Health & Beauty SE, explains: “With the realignment of the career plan, we have set an important course for sustainable profitable growth. This is likely to result in one-off, extraordinary effects in the fourth quarter, which will have a negative impact on earnings. However, in the financial year 2025 this will yield positive effects on sales and profitability.“ 

With the new logistics centre at the Ahlen site, which was put into operation in October 2024, LR sets the course for future growth. A state-of-the-art warehouse system will ensure efficiency gains and improve scaling possibilities.

The full report for the first nine months of the financial year 2024 is available online from today on the company website at https://ir.lrworld.com/. 

* As issuer of the New Bond 2024/2028, LR Health & Beauty SE publishes the figures for the third quarter and the first nine months of financial year 2024 and for the relevant periods in the previous year. The previous year’s figures for 2023 may differ from the figures for 2023 published previously by LR Global Holding GmbH. 

LR Group

Following the motto "More quality for your life" the LR Group with headquarters in Ahlen/Westphalia successfully produces and markets various high-quality nutritional supplements and cosmetic products in 32 countries. As an attractive social commerce company, LR supports the personal exchange in its community with efficient, digital solutions. The holistic tool "LR neo" offers the international partnership all business-relevant key figures and information for their LR business in one dashboard. 
 
LR has been firmly established on the market since 1985 as a "people business" company that focuses on people and personal advice. In times of changing working environments, the business model particularly appeals to those who are looking for more flexibility, a better work-life balance and greater financial independence.  
 
The processing of Aloe Vera has been one of the core competencies of LR for more than 20 years. Only the valuable inside of the leaf is used for the products. In Ahlen, the company has established one of the most modern Aloe Vera production sites for Aloe Vera Drinking Gels in Europe. 
 
In autumn 2009, LR founded the LR Global Kids Fund e.V., which supports deprived children and their families in many countries around the world efficiently and unbureaucratically in cooperation with local institutions. For further information on our commitment to sustainability, please read our sustainability report. 
 
LR currently has around 1,200 employees and hundreds of thousands of registered community members. 

Your Contacts: 
 
PR Contact:  
LR Health & Beauty SE  
Almut Kellermeyer   
Head of Corporate Communication  
Kruppstraße 55  
59227 Ahlen  
Phone: +49(0)2382 7813-106 
E-Mail: a.kellermeyer@LRworld.com 
https://ir.lrworld.com/ 
 
 
IR Contact: 
cometis AG 
Thorben Burbach 
Unter den Eichen 7 | Gebäude D 
65195 Wiesbaden 
Phone: +49(0)611 - 205855-23 
Fax: +49(0)611 - 205855-66 
E-Mail: burbach@cometis.de 

LR Health & Beauty SE confirms growth trend in the second quarter of 2024

• Sales increased to EUR 143.3 million in the first half of 2024
• Normalized EBITDA of EUR 14.4 million
• Rising demand for subscription concepts like the successful LR Health Mission 
• Growth prospects strengthened by innovative product range and planned launch of a new product segment in September

Ahlen, 30 August 2024 – LR Health & Beauty SE, Europe’s leading digital social commerce company in the area of high-quality health and beauty products, today published its figures for the second quarter of 2024 and the first half of 2024. In the second quarter of financial year 2024, LR Health & Beauty SE managed to increase sales (revenue from goods sold) by 2.6% to EUR 70.7 million (Q2 2023*: EUR 68.9 million). In the first half of the year, LR Health & Beauty SE thus generated sales of EUR 143.3 million (H1 2023*: EUR 140.9 million). New product launches, such as the LR Health Mission and the LR Body Mission, contributed significantly to the positive sales performance during the period.

Furthermore, LR Health & Beauty SE generated a normalized EBITDA of EUR 14.4 million in the first six months of financial year 2024, compared to EUR 17.5 million in the same period of the previous year*. The earnings performance was impacted by factors such as refinancing costs related to the early redemption of the old bond of LR Global Holding GmbH and the issuance of a New Bond by LR Health & Beauty SE, as well as negative currency effects. EBITDA reported amounted to EUR 11.7 million in the first half of 2024, compared to EUR 15.4 million in the same period of the previous year*.

Valdemaras Gordinskis, Vice President Global Controlling and Investor Relations of the LR Group, comments: “The LR Group’s business development has been very robust in the first half of the year and we have managed to achieve growth despite general consumer reticence in all of our regions. We are also pleased to see that our subscription concepts attract increasing interest. This is evidenced, for example, by the strong demand for the LR Health Mission with its novel product range. With this subscription, we offer those interested a 6 months treatment for the intestinal, liver and cellular metabolism, providing a comprehensive solution for personal health support.”

Future growth driven by digitization and IT expansion

LR Health & Beauty SE’s CEO Dr Andreas Laabs explains: “We will continue to consistently execute our corporate strategy in the second half of the year. In particular, we will drive our initiatives to optimize our marketing activities and our partner programs. At the same time, expanding our innovative product range remains high on our agenda. A new product segment is planned to be launched at the LR Business Day event with our partners in September. We are confident that the new products will be an ideal addition to our range and will open up new and attractive opportunities for our partners.”

Another important pillar for future growth is the continued digitization and expansion of the IT landscape. For this purpose, the LR Group will establish a new IT hub in Athens in order to provide high-quality IT services in-house and to develop and operate suitable business applications for social commerce.

LR Health & Beauty SE expects that it will continue to be in a position to capitalize on growth opportunities in the health and beauty markets. At the same time, the LR Group continues to face a challenging market environment and ongoing consumer reticence. Based on conservative assumptions, LR continues to expect sales at the previous year’s level and an only slightly lower or stable EBITDA for the 2024 financial year.

The full report for the first half of financial year 2024 is available online from today on the company website at https://ir.lrworld.com/. 
  

*As issuer of the New Bond 2024/2028, LR Health & Beauty SE publishes the figures for the second quarter and the first half of financial year 2024 and for the relevant periods in the previous year. The previous year’s figures for 2023 may differ from the figures for 2023 published previously by LR Global Holding GmbH.

LR Group

Following the motto "More quality for your life" the LR Group with headquarters in Ahlen/Westphalia successfully produces and markets various high-quality nutritional supplements and cosmetic products in 32 countries. As an attractive social commerce company, LR supports the personal exchange in its community with efficient, digital solutions. The holistic tool "LR neo" offers the international partnership all business-relevant key figures and information for their LR business in one dashboard. 
 
LR has been firmly established on the market since 1985 as a "people business" company that focuses on people and personal advice. In times of changing working environments, the business model particularly appeals to those who are looking for more flexibility, a better work-life balance and greater financial independence.  
 
The processing of Aloe Vera has been one of the core competencies of LR for more than 20 years. Only the valuable inside of the leaf is used for the products. In Ahlen, the company has established one of the most modern Aloe Vera production sites for Aloe Vera Drinking Gels in Europe. 
 
In autumn 2009, LR founded the LR Global Kids Fund e.V., which supports deprived children and their families in many countries around the world efficiently and unbureaucratically in cooperation with local institutions. For further information on our commitment to sustainability, please read our sustainability report. 
 
LR currently has around 1,200 employees and hundreds of thousands of registered community members. 

Your Contacts: 
 
PR Contact:  
LR Health & Beauty SE  
Almut Kellermeyer   
Head of Corporate Communication  
Kruppstraße 55  
59227 Ahlen  
Phone: +49(0)2382 7813-106 
E-Mail: a.kellermeyer@LRworld.com 
https://ir.lrworld.com/ 
 
IR Contact: 
cometis AG 
Thorben Burbach 
Unter den Eichen 7 | Gebäude D 
65195 Wiesbaden 
Phone: +49(0)611 - 205855-23 
Fax: +49(0)611 - 205855-66 
E-Mail: burbach@cometis.de 

LR Health & Beauty SE delivers good start into the 2024 financial year

• Sales of EUR 72.6 million in the first quarter of 2024
• Normalised EBITDA of EUR 7.8 million
• Focus on further expansion of innovative product range
• Digital initiatives progressing successfully

Ahlen, 28 May 2024 – LR Health & Beauty SE, Europe’s leading digital social selling company in the area of high-quality health and beauty products, today published its figures for the first quarter of 2024, according to which LR Health & Beauty SE generated sales (revenue from goods sold) of EUR 72.6 million (2022*: EUR 72.0 million). Despite unfavourable currency effects, the company thus achieved a slight increase in sales of around 0.8% compared to the first quarter of the previous year. 

In terms of earnings, LR Health & Beauty SE generated normalised EBITDA of EUR 7.8 million in the first three months of 2024, compared to EUR 8.7 million in the same period of the previous year. Earnings were impacted by the refinancing costs associated with the early redemption of the old bond of LR Global Holding GmbH and the issue of the new bond of LR Health & Beauty SE. EBITDA reported in the first quarter of 2024 was EUR 6.1 million, compared to EUR 7.8 million in the first quarter of 2023.

Valdemaras Gordinskis, Vice President Global Controlling and Investor Relations of the LR Group, comments: “All in all, LR has made a good start into the year 2024 and has achieved a sound performance in the important markets of Western and Eastern Europe. New product launches from previous periods, in particular the innovative BODY MISSION, made a significant contribution to growth in the first quarter. The success of our latest product launches once again validates our strategy.”

Integrating AI to streamline social selling processes

Dr Andreas Laabs, CEO of LR Health & Beauty SE, explains: “In 2024, we will continue to focus on the further digitalisation of our company and the use of innovative technologies to further optimise our business processes. We also strive to provide our partners with the best possible sales support through new product innovations. Our pipeline for this year includes both new products and seasonal sales promotions such as ‘Crazy Summer’. We’re also preparing the launch of a new product segment for the autumn of 2024, which will perfectly complement our product offering.”

LR is placing great focus on the further digitalisation of its business processes. For example, through the Group’s digital platform LR neo, partners can now access a wide range of information relevant to their sales activities. The company has also developed its own chatbot: “LR-Vera” is designed to support efficient customer service. The chatbot enables customer service centre staff to access a centralised knowledge pool that facilitates quick and comprehensive answers.

Outlook 2024

LR Health & Beauty SE expects that it will continue to capitalise on the growth opportunities in the Health & Beauty segments and sees this confirmed by a further increase in momentum in the second quarter of the year. Based on conservative assumptions, LR continues to expect sales at the previous year’s level and an only slightly lower or stable EBITDA for the 2024 financial year.

The full report for the first quarter of 2024 is available online from today on the company website at https://ir.lrworld.com/ 

*As issuer of the New Bond 2024/2028, LR Health & Beauty SE discloses the figures for the first quarter of 2024 and for the first quarter of the previous year 2023. The previous year’s figures for 2023 may differ from the figures for 2023 disclosed previously by LR Global Holding GmbH.

LR Group

Following the motto "More quality for your life" the LR Group with headquarters in Ahlen/Westphalia successfully produces and markets various high-quality health and beauty products in 32 countries. As an attractive social selling company, LR supports the personal exchange in its community with efficient, digital solutions. The holistic tool "LR neo" offers the international partnership all business-relevant key figures and information for their LR business in one dashboard.

LR has been firmly established on the market since 1985 as a "people business" company that focuses on people and personal advice. In times of changing working environments, the business model particularly appeals to those who are looking for more flexibility, a better work-life balance and greater financial independence.

The processing of Aloe Vera has been one of the core competencies of LR for more than 20 years. Only the valuable inside of the leaf is used for the products. In Ahlen, the company has established one of the most modern Aloe Vera production sites for Aloe Vera Drinking Gels in Europe.

In autumn 2009, LR founded the LR Global Kids Fund e.V., which supports deprived children and their families in many countries around the world efficiently and unbureaucratically in cooperation with local institutions. For further information on our commitment to sustainability, please read our sustainability report.

LR currently has around 1,200 employees and hundreds of thousands of registered community members.

Your Contacts:

PR Contact:
LR Health & Beauty SE 
Almut Kellermeyer  
Head of Corporate Communication 
Kruppstraße 55 
59227 Ahlen 
Phone: +49(0)2382 7813-106
E-Mail: a.kellermeyer@LRworld.com
https://ir.lrworld.com/

IR Contact:
cometis AG
Thorben Burbach
Unter den Eichen 7 | Gebäude D
65195 Wiesbaden
Phone: +49(0)611 - 205855-23
Fax: +49(0)611 - 205855-66
E-Mail: burbach@cometis.de

LR Health & Beauty SE reports a successful 2023 financial year and expands its innovative product range

• Sales increase to EUR 276.5 million; EBITDA reported reaches EUR 31.4 million
• Digitalisation and sales activities promote partners’ career development
• Expansion of innovative product range provides for positive business outlook

Ahlen, 30 April 2024 – LR Health & Beauty SE, Europe’s leading digital social selling company in the area of high-quality health and beauty products, today announced its final figures for the 2023 financial year. Accordingly, LR Health & Beauty SE generated sales (revenue from goods sold) of EUR 276.5 million (2022*: EUR 269.4 million). This meant that the company achieved a slight increase in sales of around 3% year-over-year despite negative currency effects. 

Furthermore, LR Health & Beauty SE achieved a normalized EBITDA of EUR 35.4 million in the 2023 financial year, compared to EUR 36.0 million in the previous year. EBITDA reported increased to EUR 31.4 million in 2023 compared to the previous year’s figure of EUR 31.1 million.

Valdemaras Gordinskis, Vice President Global Controlling and Investor Relations of the LR Group, comments: “2023 was a very strong year for LR. We were able to drive forward our strategic initiatives, and many partners saw successful career developments. With BODY MISSION and Mind Master Gold, we managed to achieve two of the three best product launches in the history of our company. Especially Mind Master Gold, a vegan health product, which is available for subscription, has been very well received by the community and has given our sales an extra boost.”

Expanding the innovative product range  

In the current financial year, LR continues to consistently implement its corporate strategy. This includes a further digitalisation of business processes. With the LR neo sales platform, the company has established a centralised platform for partners to make their business processes more efficient and better tailored to their needs. Since April 2024, the information available on this platform has been further expanded.  

As Dr. Andreas Laabs, CEO of LR Health & Beauty SE, explains, the company is also focusing on expanding its innovative product portfolio: “We have started well into the 2024 financial year and strive to give additional impulses to our partners’ activities by launching even more innovative products. With our LR Health Mission, we offer a 6 month treatment for the intestinal, liver and cellular metabolism, providing a holistic solution for health support. In April 2024, we have launched two additional products that ideally complement this cure.”

Outlook 2024

LR Health & Beauty SE is generally well-positioned to address the attractive growth opportunities in the health & beauty market. Given the high level of uncertainty in the market environment, LR expects sales to remain at last year’s level in FY 2024 despite the good start to the year, and a slightly lower or stable EBITDA, based on conservative assumptions.

The complete 2023 Annual Report is available online from today on the company website at https://ir.lrworld.com/. Please also refer to our website for the Sustainability Report 2023, which provides information on our current initiatives such as the commissioning of a new photovoltaic system at the Ahlen site.

*As issuer of the New Bond 2024/2028, LR Health & Beauty SE discloses the final figures for the 2023 financial year and for the previous year 2022. The previous year’s figures for 2022 may differ from the figures for 2022 disclosed previously by LR Global Holding GmbH.

LR Group

Following the motto "More quality for your life" the LR Group with headquarters in Ahlen/Westphalia successfully produces and markets various high-quality health and beauty products in 32 countries. As an attractive social selling company, LR supports the personal exchange in its community with efficient, digital solutions. The holistic tool "LR neo" offers the international partnership all business-relevant key figures and information for their LR business in one dashboard.

LR has been firmly established on the market since 1985 as a "people business" company that focuses on people and personal advice. In times of changing working environments, the business model particularly appeals to those who are looking for more flexibility, a better work-life balance and greater financial independence.

The processing of Aloe Vera has been one of the core competencies of LR for more than 20 years. Only the valuable inside of the leaf is used for the products. In Ahlen, the company has established one of the most modern Aloe Vera production sites for Aloe Vera Drinking Gels in Europe.

In autumn 2009, LR founded the LR Global Kids Fund e.V., which supports deprived children and their families in many countries around the world efficiently and unbureaucratically in cooperation with local institutions. For further information on our commitment to sustainability, please read our sustainability report.

LR currently has around 1,200 employees and hundreds of thousands of registered community members.

Your Contacts:

PR Contact:
LR Health & Beauty SE 
Almut Kellermeyer  
Head of Corporate Communication 
Kruppstraße 55 
59227 Ahlen 
Phone: +49(0)2382 7813-106
E-Mail: a.kellermeyer@LRworld.com
https://ir.lrworld.com/

IR Contact:
cometis AG
Thorben Burbach
Unter den Eichen 7 | Gebäude D
65195 Wiesbaden
Phone: +49(0)611 - 205855-23
Fax: +49(0)611 - 205855-66
E-Mail: burbach@cometis.de

LR Health & Beauty SE: Shareholder Quadriga Capital wins Evoco as major investor / Investors provide additional capital to fund successful growth strategy

• Quadriga Capital wins Evoco as major investor for LR Health & Beauty
• Investors support successful growth strategy with additional capital
• Settlement of New Bond 2024/2028 completed 

Ahlen, 26 March 2024 – LR Health & Beauty SE, Europe’s leading digital social selling platform in the area of high-quality health and beauty products, is attracting considerable interest from bondholders and investors with its social selling business model and clear corporate strategy. Quadriga Capital has now won private equity firm Evoco as a major investor in LR Health & Beauty. This is followed by further capital injection into the Company, providing LR Health & Beauty with more financial backing to further drive its strategic initiatives.

In addition, LR Health & Beauty SE has successfully placed its EUR 130 million New Bond (ISIN NO0013149658) with institutional investors, mainly from Germany and the rest of Europe. Settlement of the New Bond has now been completed. This provides the issuer of the legacy bond 2021/2024, LR Global Holding GmbH, with proceeds of approx. EUR 125 million for the premature refinancing of this bond.

Dr Andreas Laabs, CEO of LR Health & Beauty SE, said: “We are delighted that our business model and our strategy have been so well received by investors. This gives us the flexibility we need to execute our business strategy. 2024 is off to a very good start and we will now focus not only on further optimising our distribution model and launching new product innovations, but also on further digitalising our business processes. With our new digital platform, LR neo, we have created a central information hub for our partners, which we will expand to provide them with all the information they need to pursue their business activities.”

LR Group

Following the motto "More quality for your life" the LR Group with headquarters in Ahlen/Westphalia successfully produces and markets various high-quality health and beauty products in 32 countries. As an attractive social selling company, LR supports the personal exchange in its community with efficient, digital solutions. The holistic tool "LR neo" offers the international partnership all business-relevant key figures and information for their LR business in one dashboard.

LR has been firmly established on the market since 1985 as a "people business" company that focuses on people and personal advice. In times of changing working environments, the business model particularly appeals to those who are looking for more flexibility, a better work-life balance and greater financial independence. 

The processing of Aloe Vera has been one of the core competencies of LR for more than 20 years. Only the valuable inside of the leaf is used for the products. In Ahlen, the company has established one of the most modern Aloe Vera production sites for Aloe Vera Drinking Gels in Europe.

In autumn 2009, LR founded the LR Global Kids Fund e.V., which supports deprived children and their families in many countries around the world efficiently and unbureaucratically in cooperation with local institutions. For further information on our commitment to sustainability, please read our sustainability report.

LR currently has around 1,200 employees and hundreds of thousands of registered community members.

Your Contacts:
PR Contact: 
LR Global Holding    
Almut Kellermeyer     
Head of Corporate Communication    
Kruppstraße 55    
59227 Ahlen    
Phone: +49(0)2382 7813-106
E-Mail: a.kellermeyer@LRworld.com
https://ir.lrworld.com/

IR Contact: 
cometis AG
Thorben Burbach 
Unter den Eichen 7 | Gebäude D 
65195 Wiesbaden
Phone: +49(0)611 - 205855-23
Fax: +49(0)611 - 205855-66
E-Mail: burbach@cometis.de
 

LR Global Holding GmbH announces successful refinancing of its 2021/2025 bond and confirms strong sales and earnings figures for 2023

• Early refinancing of 2021/2025 bond in view of successful placement of New Bond with a volume of EUR 130 million by parent company LR Health & Beauty SE 
• Sales grew to EUR 276.5 million and EBITDA reported reached EUR 31.5 million in line with sales and earnings guidance for 2023
• Further expansion of innovative product portfolio planned with promising new launches

Ahlen, 29 February 2024 – LR Global Holding GmbH, Europe’s leading digital social selling platform in the area of high-quality health and beauty products, has successfully refinanced its 2021/2025 bond ahead of schedule, creating a foundation for a successful future business development. The parent company LR Health & Beauty SE has successfully placed a senior secured bond (ISIN NO0013149658) with a nominal volume of EUR 130 million, which is expected to generate proceeds of around EUR 125 million. The proceeds of this transaction will primarily be used for the refinancing of the 2021/2025 bond. The successful business development of the LR Group since its entry into the capital market is also reflected in its business figures. The LR Global Holding GmbH today released its Q4 2023 figures and confirmed its preliminary sales and earnings figures for the full year 2023, which exceed the previous year’s results. 

“We are very pleased with the successful placement of our New Bond and appreciate the strong interest and confidence shown by our investors. The early refinancing of our 2021/2025 bond and the related issuance of the New Bond provides us with the tailwind to continue to successfully execute our corporate strategy. In particular, we intend to focus on the launch of innovative new products and the continued digitalisation of our business in order to best support our partners in their career development,” Dr Andreas Laabs, CEO of LR Health & Beauty SE, explains.

The LR Group was able to close the financial year 2023 with strong figures. Its sales (revenue from goods sold) amounted to EUR 70.9 million in Q4 2024 (Q4 2022: EUR 72.8 million), which is just 2.7% below the previous year’s figure despite adverse currency effects. FY 2023 sales of the LR Group thus amounted to EUR 276.5 million (FY 2022: EUR 269.4 million). This corresponds to an increase of 2.6% and is within the guidance range for 2023 of EUR 275 to 280 million.

In addition, the LR Group achieved a EBITDA reported of EUR 8.9 million in Q4 2023, compared to EUR 12.8 million in the previous year’s quarter, which had benefited from extraordinary effects. FY 2023 EBITDA reported amounted to EUR 31.5 million, slightly above the previous year’s level of EUR 31.3. million. The normalized EBITDA, however, fell from EUR 13.8 million in Q4 2022 to EUR 10.1 million in Q4 2023, as the previous year’s quarter had benefited from extraordinary effects. Normalized EBITDA for the full year 2023 thus amounted to EUR 35.5 million (FY 2022: EUR 36.3 million). 

Valdemaras Gordinskis, LR Group’s Vice President Global Controlling and Investor Relations, comments: “The increase in sales and earnings in FY 2023 reflects the success of our initiatives to support the career development of our partners, as well as the expansion of our product portfolio in the health and beauty segment. Our strategic focus remains on supporting our partners with a strong 2024 agenda. We are working intensively on new product concepts and plan to launch both innovative new products and complementary products to our existing categories this year. In addition, we are digitising our processes to provide our partners with all the information they need for their activities via our new digital platform: LR neo. At the same time, we continue to prioritise cross-sponsorship and international expansion, enabling our partners to extend their social selling beyond national boundaries.”

The report on the fourth quarter of 2023 is available from today on the company website https://ir.lrworld.com/. The final, audited figures for financial year 2023 will be published together with the Annual Report on the company website at the end of April 2024. 

LR Group

Following the motto "More quality for your life" the LR Group with headquarters in Ahlen/Westphalia successfully produces and markets various high-quality health and beauty products in 32 countries. As an attractive social selling company, LR supports the personal exchange in its community with efficient, digital solutions. The holistic tool "LR neo" offers the international partnership all business-relevant key figures and information for their LR business in one dashboard.

LR has been firmly established on the market since 1985 as a "people business" company that focuses on people and personal advice. In times of changing working environments, the business model particularly appeals to those who are looking for more flexibility, a better work-life balance and greater financial independence. 

The processing of Aloe Vera has been one of the core competencies of LR for more than 20 years. Only the valuable inside of the leaf is used for the products. In Ahlen, the company has established one of the most modern Aloe Vera production sites for Aloe Vera Drinking Gels in Europe.

In autumn 2009, LR founded the LR Global Kids Fund e.V., which supports deprived children and their families in many countries around the world efficiently and unbureaucratically in cooperation with local institutions. For further information on our commitment to sustainability, please read our sustainability report.

LR currently has around 1,200 employees and hundreds of thousands of registered community members.

Your Contacts:

PR Contact: 
LR Global Holding    
Almut Kellermeyer     
Head of PR / Public Affairs    
Kruppstraße 55    
59227 Ahlen    
Phone: +49(0)2382 7060-106
E-Mail: a.kellermeyer@LRworld.com
https://ir.lrworld.com/

IR Contact: 
cometis AG
Thorben Burbach 
Unter den Eichen 7 | Gebäude D 
65195 Wiesbaden
Phone: +49(0)611 - 205855-23
Fax: +49(0)611 - 205855-66
E-Mail: burbach@cometis.de 

NOT FOR PUBLICATION OR DISTRIBUTION IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, CYPRUS, HONG KONG, ITALY, JAPAN, NEW ZEALAND, SOUTH AFRICA, THE UNITED KINGDOM OR ANY OTHER JURISDICTION WHERE SUCH DISTRIBUTION WOULD REQUIRE ANY FURTHER MEASURES FROM LR GLOBAL HOLDING GMBH, LR HEALTH & BEAUTY SE, PARETO SECURITIES AS, FRANKFURT BRANCH, ARCTIC SECURITIES AS OR ANY OTHER PARTY.

LR Global Holding GmbH achieves sales and earnings growth in 2023 and aims to refinance its 2021/2025 bond ahead of time

• Consistent implementation of strategic measures since the LR Group entered the capital market is paying off: according to preliminary figures, the Company generated sales of EUR 276.5 million in line with its forecast and achieved EBITDA reported of EUR 31.5 million at the upper end of the forecast range
• Social Selling as a business model and the portfolio of innovative health and beauty products offer attractive growth potential
• Refinancing of 2021/2025 bond planned through issuance of a new senior secured bond with a volume of EUR 125 million by parent company LR Health & Beauty SE

Ahlen, 13 February 2024 – LR Global Holding GmbH (the “Company”), Europe’s leading digital social selling company in the area of high-quality health and beauty products, continued its successful business development in financial year 2023 and achieved its sales and earnings forecasts for 2023. According to preliminary figures, LR increased sales by around 3% year-over-year to EUR 276.5 million in 2023 (2022: EUR 269.4 million) despite negative currency effects, which is in line with its sales forecast range for 2023 of EUR 275.0 million to EUR 280.0 million. In addition, based on preliminary figures, the LR Group achieved EBITDA reported in 2023 of EUR 31.5 million (2022: EUR 31.3 million), thus reaching the upper end of its EBITDA forecast range of EUR 28 million to EUR 32 million. Normalized FY 2023 EBITDA amounted to EUR 35.5 million (2022: EUR 36.3 million).

"The initiatives implemented to promote the career development of our partners as well as the expansion of our innovative product portfolio made a significant contribution to the company’s success in the 2023 financial year. In 2024, we will continue to focus on our strategic measures to expand LR’s market position as the leading digital social selling company. We thus strive to further address megatrends such as health and the increasing importance of digital and flexible working models and provide our partners with the best possible support in successfully developing their careers,” says Dr Andreas Laabs, Chief Executive Officer (CEO) of LR Health & Beauty SE.

Early repayment of the 2021/2025 bond in the event of a successful new issue 

Driven by an even stronger positioning in the market as well as sales and earnings growth in FY 2023, the Company intends to refinance its senior secured 2021/2025 bond, ISIN NO0010894850 (the “Existing Bond”) with a volume of EUR 125 million. For this purpose, the parent company LR Health & Beauty SE plans to issue a euro-denominated senior secured corporate bond (the “New Bond”) with a target volume of EUR 125 million. The final terms and conditions of the New Bond and the annual coupon are expected to be determined after completion of the bookbuilding process of the private placement and will be published together with further information in the event of a successful New Bond issue.

Dr Andreas Laabs explains: “Having issued our first corporate bond in 2021, we have since successfully established ourselves on the capital market. By issuing a New Bond, we now see the opportunity to continue to diversify our financing structure for the coming years and create the conditions for future growth. We are therefore seeking to refinance the Existing Bond by issuing a New Bond in the “Nordic Bond” format. In recent years, we have successfully driven the LR Group’s business performance based on the consistent digitalisation of our business model and the expansion of our range of innovative health and beauty products. Together with our strong partner community and financing partners, we strive to systematically continue this path.”

LR Health & Beauty SE plans to issue a New Bond as part of a private placement to institutional investors, primarily in Germany and other European countries. The New Bond is set to be issued in the so-called “Nordic Bond” format under Swedish law, with Nordic Trustee & Agency AB (publ) as trustee. The LR Group aims to list the New Bond on the Open Market of the Frankfurt Stock Exchange. In addition, it is intended that the New Bond will be listed at Nasdaq Stockholm within a period of twelve months. In accordance with the terms and conditions of the 2021/2025 Existing Bond, the Company intends to redeem the Existing Bond at a price of 101.45% of its principal amount (plus accrued but unpaid interest) following the successful issue of the New Bond.

LR Group

Following the motto "More quality for your life" the LR Group with headquarters in Ahlen/Westphalia successfully produces and markets various high-quality health and beauty products in 32 countries. As an attractive social selling company, LR supports the personal exchange in its community with efficient, digital solutions. The holistic tool "LR neo" offers the international partnership all business-relevant key figures and information for their LR business in one dashboard.

LR has been firmly established on the market since 1985 as a "people business" company that focuses on people and personal advice. In times of changing working environments, the business model particularly appeals to those who are looking for more flexibility, a better work-life balance and greater financial independence. 

The processing of Aloe Vera has been one of the core competencies of LR for more than 20 years. Only the valuable inside of the leaf is used for the products. In Ahlen, the company has established one of the most modern Aloe Vera production sites for Aloe Vera Drinking Gels in Europe.

In autumn 2009, LR founded the LR Global Kids Fund e.V., which supports deprived children and their families in many countries around the world efficiently and unbureaucratically in cooperation with local institutions. For further information on our commitment to sustainability, please read our sustainability report.

LR currently has around 1,200 employees and hundreds of thousands of registered community members.

Your Contacts:

PR Contact: 
LR Global Holding    
Almut Kellermeyer     
Head of PR / Public Affairs    
Kruppstraße 55    
59227 Ahlen    
Phone: +49(0)2382 7060-106
E-Mail: a.kellermeyer@LRworld.com
https://ir.lrworld.com/

IR Contact: 
cometis AG
Thorben Burbach 
Unter den Eichen 7 | Gebäude D 
65195 Wiesbaden
Phone: +49(0)611 - 205855-23
Fax: +49(0)611 - 205855-66
E-Mail: burbach@cometis.de 

Important Note

THE SECURITIES MENTIONED HEREIN HAVE NOT BEEN, AND WILL NOT BE, REGISTERED UNDER THE US SECURITIES ACT. THEY MAY NOT BE OFFERED OR SOLD IN THE UNITED STATES, EXCEPT PURSUANT TO AN EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE U.S. SECURITIES ACT. NO PUBLIC OFFERING WILL BE MADE IN THE UNITED STATES AND THE INFORMATION CONTAINED HEREIN DOES NOT CONSTITUTE AN OFFER TO SELL NOR A SOLICITATION TO BUY OR SUBSCRIBE FOR SECURITIES OF LR GLOBAL HOLDING GMBH AND/OR LR HEALTH & BEAUTY SE AND NO EXCHANGE OFFER IS BEING MADE IN THE UNITED STATES, AUSTRALIA, CANADA, CYPRUS, HONG KONG, ITALY, JAPAN, NEW ZEALAND, SOUTH AFRICA, THE UNITED KINGDOM OR ANY OTHER JURISDICTION WHERE SUCH DISTRIBUTION/SUCH OFFER WOULD REQUIRE ANY FURTHER MEASURES FROM LR GLOBAL HOLDING GMBH, LR HEALTH & BEAUTY SE, PARETO SECURITIES AS, FRANKFURT BRANCH, ARCTIC SECURITIES AS OR ANY OTHER PARTY OR BE PROHIBITED BY APPLICABLE LAW.